Does metabolically healthy obesity exist?

Nutrients

Volumn 8, Issue 6, 2016, Pages

  Muñoz Garach, Araceli ^a,b   Cornejo Pareja, Isabel ^a   Tinahones, Francisco J ^a,b  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Adipose tissue; Inflammation; Metabolic syndrome; Metabolically healthy obesity

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; FATTY ACID; GLUCOSE; GLYCEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 4; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RANTES; RETINOL BINDING PROTEIN 4; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D;

ADIPOGENESIS; ADIPOSE TISSUE; BODY MASS; CARDIOVASCULAR RISK; FAT CONTENT; HOMEOSTASIS; HUMAN; HYPERINSULINEMIC-EUGLYCEMIC CLAMP TECHNIQUE; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEUKOCYTE COUNT; LIFESTYLE; LIPID STORAGE; METABOLIC DISORDER; METABOLIC SYNDROME X; METABOLICALLY HEALTHY OBESITY; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; PREVALENCE; REVIEW; TISSUE EXPANSION; CARDIOVASCULAR DISEASES; HEALTH STATUS; METABOLIC DISEASES; METABOLISM; RISK FACTOR;

CARDIOVASCULAR DISEASES; HEALTH STATUS; HUMANS; METABOLIC DISEASES; OBESITY; RISK FACTORS;

EID: 84971467523     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8060320     Document Type: Review

References (72)

1. Sims, E. Are there persons who are obese, but metabolically healthy? Metabolism 2001, 50, 1499-1504
2. Roberson, L.; Aneni, E.; Maziak, W.; Agatston, A.; Feldman, T.; Rouseff, M.; Tran, T.; Blaha, M.J.; Santos, R.D.; Sposito, A.; et al. Beyond BMI: The “Metabolically healthy obese” phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality-A systematic review. BMC Public Health 2014, 14, 1-12.
3. Wildman, R.; Muntner, P.; Reynolds, K.; McGinn, A.; Rajpathak, S.; Wylie-Rosett, J.; Sowers, M.R. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: Prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch. Intern. Med. 2008, 168, 1617-1624
4. Pajunen, P.; Kotronen, A.; Korpi-Hyövälti, E.; Keinänen-Kiukaanniemi, S.; Oksa, H.; Niskanen, L.; Saaristo, T.; Saltevo, J.T.; Sundvall, T.; Vanhala, M.; et al. Metabolically healthy and unhealthy obesity phenotypes in the general population: The FIN-D2D survey. BMC Public Health 2011, 1, 754-762
5. Shea, J.; Randell, E.; Sun, G. The prevalence of metabolically healthy obese subjects defined by BMI and dual-energy X-ray absorptiometry. Obesity (Silver Spring) 2011, 19, 624-630
6. Van Vliet-Ostaptchouk, J.; Nuotio, M.; Slagter, S.; Doiron, D.; Fischer, K.; Foco, L.; Gaye, A.; Gögele, M.; Heier, M.; Hiekkalinna, T.; et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: A collaborative analysis of ten large cohort studies. BMC Endocr. Disord. 2014, 14, 9-22
7. Karelis, A. Metabolically healthy but obese individuals. Lancet 2008, 372, 1281-1283
8. Blüher, M. The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals. Curr. Opin. Lipidol. 2010, 21, 38-43
9. Brochu, M.; Tchernof, A.; Dionne, I.; Sites, C.K.; Eltabbakh, G.H.; Sims, E.A.; Poehlman, E.T. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J. Clin. Endocrinol. Metab. 2001, 86, 1020-1025
10. Karelis, A.; Faraj, M.; Bastard, J.; St-Pierre, D.; Brochu, M.; Prud’homme, D.; Rabasa-Lhoret, R. The metabolically healthy but obese individual presents a favorable inflammation profile. J. Clin. Endocrinol. Metab. 2005, 90, 4145-4150
11. Kantartzis, K.; Machann, J.; Schick, F.; Rittig, K.; Machicao, F.; Fritsche, A.; Häring, H.-U.; Stefan, N. Effects of a lifestyle intervention in metabolically benign and malign obesity. Diabetologia 2011, 54, 864-868
12. Stefan, N.; Kantartzis, K.; Machann, J.; Schick, F.; Thamer, C.; Rittig, K.; Balletshofer, B.; Machicao, F.; Fritsche, A.; Häring, H.U. Identification and characterization of metabolically benign obesity in humans. Arch. Intern. Med. 2008, 168, 1609-1616
13. Camhi, S.M.; Katzmarzyk, P.T. Differences in body composition between metabolically healthy obese and metabolically abnormal obese adults. Int. J. Obes. (Lond.) 2014, 38, 1142-1145
14. Bobbioni-Harsch, E.; Pataky, Z.; Makoundou, V.; Laville, M.; Disse, E.; Anderwald, C.; Konrad, T.; Golay, A. Frommetabolic normality to cardiometabolic risk factors in subjects with obesity. Obesity (Silver Spring) 2012, 20, 2063-2069
15. Aguilar-Salinas, C.; García, E.; Robles, L.; Riaño, D.; Ruiz-Gomez, D.; García-Ulloa, A.; Melgarejo, M.A.; Zamora, M.; Guillen-Pineda, L.E.; Mehta, R.; et al. High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J. Clin. Endocrinol. Metab. 2008, 93, 4075-4079
16. Karelis, A.; Rabasa-Lhoret, R. Obesity: Can inflammatory status define metabolic health? Nat. Rev. Endocrinol. 2013, 9, 694-695
17. Hamer, M.; Stamatakis, E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J. Clin. Endocrinol. Metab. 2012, 97, 2482-2488
18. Phillips, C.M.; Dillon, C.; Harrington, J.M.; McCarthy, V.J.C.; Kearney, P.M.; Fitzgerald, A.P.; Perry, I.J. Defining metabolically healthy obesity: Role of dietary and lifestyle factors. PLoS ONE 2013, 8, e76188
19. Sutherland, J.; McKinley, B.; Eckel, R. The metabolic syndrome and inflammation. Metab. Syndr. Relat. Disord. 2004, 2, 82-104
20. DeBoer, M. Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: A need for screening tools to target interventions. Nutrition 2013, 29, 379-386
21. Phillips, C.; Perry, I. Does inflammation determine metabolic health status in obese and nonobese adults? J. Clin. Endocrinol. Metab. 2013, 98, E1610-E1619
22. Ouchi, N.; Parker, J.L.; Lugus, J.J.; Walsh, K. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 2011, 11, 85-97
23. VanBeek, L.; Lips, M.; Visser, A.; Pijl, H.; Ioan-Facsinay, A.; Toes, R.; Berends, F.J.; van Dijk, K.W.; Koning, F.; van Harmelen, V. Increased systemic and adipose tissue inflammation differentiates obese women with T2DM from obese women with normal glucose tolerance. Metabolism 2014, 63, 492-501
24. Blüher, S.; Schwarz, P. Metabolically healthy obesity from childhood to adulthood-does weight status alone matter? Metabolism 2014, 63, 1084-1092
25. Barbarroja, N.; López-Pedrera, R.; Mayas, M.D.; García-Fuentes, E.; Garrido-Sánchez, L.; Macías-González, M.; Bekay, R.; Vidal-Puig, A.; Tinahones, F.J. The obese healthy paradox: Is inflammation the answer? Biochem. J. 2010, 430, 141-149
26. Lionetti, L.; Mollica, M.P.; Lombardi, A.; Cavaliere, G.; Gifuni, G.; Barletta, A. From chronic overnutrition to insulin resistance: The role of fat-storing capacity and inflammation. Nutr. Metab. Cardiovasc. Dis. 2009, 19, 146-152
27. De Ferranti, S.; Mozaffarian, D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin. Chem. 2008, 54, 945-955
28. Ledoux, S.; Queguiner, I.; Msika, S.; Calderari, S.; Rufat, P.; Gasc, J.M.; Corvol, P.; Larger, E. Angiogenesis associated with visceral and subcutaneous adipose tissue in severe human obesity. Diabetes 2008, 57, 3247-3257
29. Arner, E.; Westermark, P.O.; Spalding, K.L.; Britton, T.; Rydén, M.; Frisén, J.; Bernard, S.; Arner, P. Adipocyte turnover: Relevance to human adipose tissue morphology. Diabetes 2010, 59, 105-109
30. Virtue, S.; Vidal-Puig, A. It’s not how fat you are, it’s what you do with it that counts. PLoS Biol. 2008, 6, e237
31. Barbarroja, N.; Rodriguez-Cuenca, S.; Nygren, H.; Camargo, A.; Pirraco, A.; Relat, J.; Cuadrado, I.; Pellegrinelli, V.; Medina-Gomez, G.; Lopez-Pedrera, C.; et al. Increased dihydroceramide/ceramide ratio mediated by defective expression of degs1 impairs adipocyte differentiation and function. Diabetes 2015, 64, 1180-1192
32. Spalding, K.L.; Arner, E.; Westermark, P.O.; Bernard, S.; Buchholz, B.A.; Bergmann, O.; Blomqvist, L.; Hoffstedt, J.; Näslund, E.; Britton, T.; et al. Dynamics of fat cell turnover in humans. Nature 2008, 453, 783-787
33. Baglioni, S.; Francalanci, M.; Squecco, R.; Lombardi, A.; Cantini, G.; Angeli, R.; Gelmini, S.; Guasti, D.; Benvenuti, S.; Annunziato, F.; et al. Characterization of human adult stem-cell populations isolated from visceral and subcutaneous adipose tissue. FASEB J. 2009, 23, 3494-3505
34. Isakson, P.; Hammarstedt, A.; Gustafson, B.; Smith, U. Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation. Diabetes 2009, 58, 1550-1557
35. Cleveland-Donovan, K.; Maile, L.A.; Tsiaras, W.G.; Tchkonia, T.; Kirkland, J.L.; Boney, C.M. IGF-I activation of the AKT pathway is impaired in visceral but not subcutaneous preadipocytes from obese subjects. Endocrinology 2010, 151, 3752-3763
36. Roldan, M.; Macias-Gonzalez, M.; Garcia, R.; Tinahones, F.J.; Martin, M. Obesity short-circuits stemness gene network in human adipose multipotent stem cells. FASEB J. 2011, 25, 4111-4126
37. Sorisky, A.; Gagnon, A.M. Clinical implications of adipose tissue remodelling: Adipogenesis and apoptosis. Can. J. Diabetes 2002, 26, 232-240.
38. Arner, P.; Spalding, K.L. Fat cell turnover in humans. Biochem. Biophys. Res. Commun. 2010, 396, 101-104
39. Ortega, F.J.; Mayas, D.; Moreno-Navarrete, J.M.; Catalán, V.; Gómez-Ambrosi, J.; Esteve, E.; Rodriguez-Hermosa, J.I.; Ruiz, B.; Ricart, W.; Peral, B.; et al. The gene expression of the main lipogenic enzymes is downregulated in visceral adipose tissue of obese subjects. Obesity 2010, 18, 13-20
40. Clemente-Postigo, M.; Queipo-Ortuño, M.I.; Fernandez-Garcia, D.; Gomez-Huelgas, R.; Tinahones, F.J.; Cardona, F. Adipose tissue gene expression of factors related to lipid processing in obesity. PLoS ONE 2011, 6, e24783
41. Cao, Y. Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Nat. Rev. Drug Discov. 2010, 9, 107-115
42. Tinahones, F.J.; Coín-Aragüez, L.; Mayas, M.D.; Garcia-Fuentes, E.; Hurtado-Del-Pozo, C.; Vendrell, J.; Cardona, F.; Calvo, R.M; Obregon, M.J.; Bekay, E.L.R. Obesity-associated insulin resistance is correlated to adipose tissue vascular endothelial growth factors and metalloproteinase levels. BMC Physiol. 2012, 12
43. Tinahones, F.J.; Coín-Aragüez, L.; Murri, M.; Oliva-Olivera, W.; Mayas Torres, M.D.; Barbarroja, N.; Gomez-Huelgas, R.; Malagón, M.M.; Bekay, E.L.R. Caspase induction and BCL2 inhibition in human adipose tissue: A potential relationship with insulin signaling alteration. Diabetes Care 2013, 36, 513-521
44. Bluher, S.; Markert, J.; Herget, S.; Yates, T.; Davis, M.; Muller, G.; Waldow, T.; Schwarz, P.E. Who should we target for diabetes prevention and diabetes risk reduction? Curr. Diabetes Rep. 2012, 12, 147-156
45. Mitchell, P.S.; Parkin, R.K.; Kroh, E.M.; Fritz, B.R.; Wyman, S.K.; Pogosova-Agadjanyan, E.L.; Peterson, A.; Noteboom, J.; O’Briant, K.C.; Allen, A.; et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA 2008, 105, 10513-10518
46. Zhang, T.; Lv, C.; Li, L.; Chen, S.; Liu, S.; Wang, C.; Su, B. Plasma miR-126 is a potential biomarker for early prediction of type 2 diabetes mellitus in susceptible individuals. BioMed Res. Int. 2013, 2013, 6
47. Ortega, F.; Lee, D.; Katzmarzyk, P.; Ruiz, J.; Sui, X.; Church, T. The intriguing metabolically healthy but obese phenotype: Cardiovascular prognosis and role of fitness. Eur. Heart J. 2013, 34, 389-397
48. Katzmarzyk, P.; Church, T.; Janssen, I.; Ross, R.; Blair, S. Metabolic syndrome, obesity, and mortality: Impact of cardiorespiratory fitness. Diabetes Care 2005, 28, 391-397
49. Larsson, C.; Krøll, L.; Bennet, L.; Gullberg, B.; Råstam, L.; Lindblad, U. Leisure time and occupational physical activity in relation to obesity and insulin resistance: A population-based study from the Skaraborg Project in Sweden. Metabolism 2012, 61, 590-598
50. Arsenault, B.J.; Côté, M.; Cartier, A.; Lemieux, I.; Després, J.P.; Ross, R.; Earnest, C.P.; Blair, S.N.; Church, T.S. Effect of exercise training on cardiometabolic risk markers among sedentary, but metabolically healthy overweight or obese post-menopausal women with elevated blood pressure. Atherosclerosis 2009, 207, 530-533
51. Janiszewski, P.M.; Ross, R. Effects of weight loss among metabolically healthy obese men and women. Diabetes Care 2010, 33, 1957-1959
52. Karelis, A.; Messier, V.; Brochu, M.; Rabasa-Lhoret, R. Metabolically healthy but obese women: Effect of an energy-restricted diet. Diabetologia 2008, 51, 1752-1754
53. Martínez-González, M.A.; Salas-Salvadó, J.; Estruch, R.; Corella, D.; Fitó, M.; Ros, E. PREDIMED INVESTIGATORS. Benefits of the Mediterranean diet: Insights from the PREDIMED Study. Prog. Cardiovasc. Dis. 2015, 58, 50-60.
54. Dalzill, C.; Nigam, A.; Juneau, M.; Guilbeault, V.; Latour, E.; Mauriège, P.; Gayda, M. Intensive lifestyle intervention improves cardiometabolic and exercise parameters in metabolically healthy obese and metabolically unhealthy obese in dividuals. Can. J. Cardiol. 2014, 30, 434-440
55. Samaropoulos, X.F.; Hairston, K.G.; Anderson, A.; Haffner, S.M.; Lorenzo, C.; Montez, M. A metabolically healthy obese phenotype in Hispanic participants in the IRAS family study. Obesity (Silver Spring) 2013, 21, 2303-2309
56. Buchwald, H.; Avidor, Y.; Braunwald, E.; Jensen, M.D.; Pories, W.; Fahrbach, K. Bariatric surgery: A systematic review and meta-analysis. JAMA 2004, 292, 1724-1737
57. Hinnouho, G.M.; Czernichow, S.; Dugravot, A.; Nabi, H.; Brunner, E.J.; Kivimaki, M. Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: The Whitehall II cohort study. Eur. Heart J. 2015, 36, 551-559
58. Hwang, Y.C.; Hayashi, T.; Fujimoto, W.Y.; Kahn, S.E.; Leonetti, D.L.; McNeely, M.J. Visceral abdominal fat accumulation predicts the conversion of metabolically healthy obese subjects to an unhealthy phenotype. Int. J. Obes. 2015, 39, 1365-1370
59. Soriguer, F.; Gutierrez-Repiso, C.; Rubio-Martin, E.; Garcia-Fuentes, E.; Almaraz, M.C.; Colomo, N. Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study. J. Clin. Endocrinol. Metab. 2013, 98, 2318-2325
60. Song, Y.; Manson, J.E.; Meigs, J.B.; Ridker, P.M.; Buring, J.E.; Liu, S. Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women. Am. J. Cardiol. 2007, 100, 1654-1658
61. Meigs, J.B.; Wilson, P.W.; Fox, C.S.; Vasan, R.S.; Nathan, D.M.; Sullivan, L.M. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J. Clin. Endocrinol. Metab. 2006, 91, 2906-2912
62. Calori, G.; Lattuada, G.; Piemonti, L.; Garancini, M.P.; Ragogna, F.; Villa, M. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: The Cremona Study. Diabetes Care 2011, 34, 210-215
63. Ogorodnikova, A.D.; Kim, M.; McGinn, A.P.; Muntner, P.; Khan, U.; Wildman, R.P. Incident cardiovascular disease events in metabolically benign obese individuals. Obesity (Silver Spring) 2012, 20, 651-659
64. Arnlov, J.; Ingelsson, E.; Sundstrom, J.; Lind, L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2010, 121, 230-236
65. Flint, A.J.; Hu, F.B.; Glynn, R.J.; Caspard, H.; Manson, J.E.; Willett, W.C. Excess weight and the risk of incident coronary heart disease among men and women. Obesity (Silver Spring) 2010, 18, 377-383
66. Kramer, C.K.; Zinman, B.; Retnakaran, R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann. Intern. Med. 2013, 159, 758-769
67. Shaharyar, S.; Roberson, L.L.; Jamal, O.; Younus, A.; Blaha, M.J.; Ali, S.S. Obesity and metabolic phenotypes (metabolically healthy and unhealthy variants) are significantly associated with prevalence of elevated C-reactive protein and hepatic steatosis in a large healthy Brazilian population. J. Obes. 2015, 2015, 178526
68. Eshtiaghi, R.; Keihani, S.; Hosseinpanah, F.; Barzin, M.; Azizi, F. Natural course of metabolically healthy abdominal obese adults after 10 years of follow-up: The Tehran Lipid and Glucose Study. Int. J. Obes. 2015, 39, 514-519
69. Li, S.; Chen, W.; Srinivasan, S.; Xu, J.; Berenson, G. Relation of childhood obesity/cardiometabolic phenotypes to adult cardiometabolic profile: The Bogalusa Heart Study. Am. J. Epidemiol. 2012, 176, S142-S149
70. Dvorak, R.; DeNino, W.; Ades, P.; Poehlman, E. Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women. Diabetes 1999, 48, 2210-2214
71. Park, J.; Kim, S.; Cho, G.; Baik, I.; Kim, N.; Lim, H. Obesity phenotype and cardiovascular changes. J. Hypertens. 2011, 29, 1765-1772
72. Khan, U.; Wang, D.; Thurston, R.; Sowers, M.; Sutton-Tyrrell, K.; Matthews, K. Burden of subclinical cardiovascular disease in “metabolically benign” and “at-risk” overweight and obese women: The Study of Women’s Health Across the Nation (SWAN). Atherosclerosis 2011, 217, 179-186